No products in the cart.
Bdparib 200 mg (Rucaparib)
Bdparib 200 mg contains Rucaparib, a targeted PARP inhibitor used to treat advanced ovarian cancer in BRCA mutation-positive patients.
Bdparib 200 mg (Rucaparib)
| Active Ingredient | Rucaparib |
|---|---|
| Indication: | Treatment of Prostate and Ovarian Cancers |
| Manufacturer: | BDR Pharmaceuticals |
| Packaging | 60 Tablets in bottle |
| Strength | 200mg |
Bdparib 200mg contains Rucaparib, a PARP inhibitor (poly ADP-ribose polymerase inhibitor) used in the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer, particularly in patients with BRCA gene mutations. It is most often prescribed in advanced or relapsed cases, including as maintenance therapy after successful platinum-based chemotherapy.
Rucaparib works by interfering with cancer cells’ ability to repair their DNA, leading to cell death—particularly in tumors with BRCA mutations that are already DNA-repair deficient. Bdparib 200 mg tablets are taken orally, usually twice daily, and are monitored closely by an oncologist for efficacy and side effects.
| pack size | 60 Tablets – USD $9 Per pill, 120 Tablets – USD $8.75 Per pill, 180 Tablets – USD $8.44 Per pill |
|---|
Be the first to review “Bdparib 200 mg (Rucaparib)”
You must be logged in to post a review.
Related Products
Buy Veenat 100 Capsule (Imatinib)
Price range: $64.00 through $195.00
Buy Imat 400 Mg (Imatinib)
Price range: $130.00 through $375.00
Buy Armotraz 1 Mg (Anastrozole)
Price range: $50.00 through $150.00
Buy Tamoxifen 10 Mg (Tamoxifen)
Price range: $25.00 through $57.00
There are no reviews yet.